SMS Pharmaceuticals has informed that the Company has sent a detailed communication on 24th August, 2022 to all the Shareholders, whose email IDs are registered with the Company/Depositories, indicating information regarding deduction of Income Tax at source on dividend and the process and documentation required for claiming exemption from deduction / withholding of tax on dividends. A specimen copy of the said communication sent to the shareholders is enclosed. This communication is also being made available on the website of the Company www.smspharma.com at Investors Section.
The above information is a part of company’s filings submitted to BSE.
